These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11174067)
1. Increased cell surface expression of receptors for transforming growth factor-beta on osteoblasts from patients with Osteogenesis imperfecta. Gebken J; Brenner R; Feydt A; Notbohm H; Brinckmann J; Müller PK; Bätge B Pathobiology; 2000; 68(3):106-12. PubMed ID: 11174067 [TBL] [Abstract][Full Text] [Related]
2. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821 [TBL] [Abstract][Full Text] [Related]
3. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta. Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854 [TBL] [Abstract][Full Text] [Related]
4. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts. Fedarko NS; Sponseller PD; Shapiro JR J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177 [TBL] [Abstract][Full Text] [Related]
5. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Wolf G; Schroeder R; Ziyadeh FN; Stahl RA Kidney Int; 2004 Nov; 66(5):1849-58. PubMed ID: 15496155 [TBL] [Abstract][Full Text] [Related]
6. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells. Takeuchi Y; Fukumoto S; Matsumoto T J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639 [TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Yu Z; Xing Y Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076 [TBL] [Abstract][Full Text] [Related]
8. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta. Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219 [TBL] [Abstract][Full Text] [Related]
9. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients. Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286 [TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta. Mörike M; Windsheimer E; Brenner R; Nerlich A; Bushart G; Teller W; Vetter U J Orthop Res; 1993 Jul; 11(4):564-72. PubMed ID: 8340828 [TBL] [Abstract][Full Text] [Related]
11. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age. Fedarko NS; D'Avis P; Frazier CR; Burrill MJ; Fergusson V; Tayback M; Sponseller PD; Shapiro JR J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947 [TBL] [Abstract][Full Text] [Related]
12. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis. Kang H; Aryal Ac S; Barnes AM; Martin A; David V; Crawford SE; Marini JC J Bone Miner Res; 2022 May; 37(5):925-937. PubMed ID: 35258129 [TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. Fedarko NS; Moerike M; Brenner R; Robey PG; Vetter U J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206 [TBL] [Abstract][Full Text] [Related]
14. Age-related differences in the expression of receptors for TGF-beta in human osteoblast-like cells in vitro. Bätge B; Feydt A; Gebken J; Klein H; Notbohm H; Müller PK; Brinckmann J Exp Clin Endocrinol Diabetes; 2000; 108(4):311-5. PubMed ID: 10961364 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone enhancement of betaglycan (TGF-beta type III receptor) gene expression in osteoblast-like cells. Nakayama H; Ichikawa F; Andres JL; Massagué J; Noda M Exp Cell Res; 1994 Apr; 211(2):301-6. PubMed ID: 8143777 [TBL] [Abstract][Full Text] [Related]
16. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome. Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342 [TBL] [Abstract][Full Text] [Related]
17. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells. Lee EH; Joo CK Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257 [TBL] [Abstract][Full Text] [Related]
18. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta. Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807 [TBL] [Abstract][Full Text] [Related]
19. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264 [TBL] [Abstract][Full Text] [Related]
20. COL1A2 and COL2A1 expression in temporal bone of lethal osteogenesis imperfecta. Khetarpal U; Morton CC Arch Otolaryngol Head Neck Surg; 1993 Dec; 119(12):1305-14. PubMed ID: 17431984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]